CN109517012B - 一种透明质酸寡糖的制备方法 - Google Patents
一种透明质酸寡糖的制备方法 Download PDFInfo
- Publication number
- CN109517012B CN109517012B CN201811346941.5A CN201811346941A CN109517012B CN 109517012 B CN109517012 B CN 109517012B CN 201811346941 A CN201811346941 A CN 201811346941A CN 109517012 B CN109517012 B CN 109517012B
- Authority
- CN
- China
- Prior art keywords
- hyaluronic acid
- acid oligosaccharide
- purity
- ion exchange
- oligosaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920001542 oligosaccharide Polymers 0.000 title claims abstract description 121
- 229920002674 hyaluronan Polymers 0.000 title claims abstract description 112
- 229960003160 hyaluronic acid Drugs 0.000 title claims abstract description 110
- -1 hyaluronic acid oligosaccharide Chemical class 0.000 title claims abstract description 65
- 238000002360 preparation method Methods 0.000 title abstract description 12
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 47
- 238000004519 manufacturing process Methods 0.000 claims abstract description 19
- 238000005342 ion exchange Methods 0.000 claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 108010003272 Hyaluronate lyase Proteins 0.000 claims abstract description 7
- 229960002773 hyaluronidase Drugs 0.000 claims abstract description 7
- 102000001974 Hyaluronidases Human genes 0.000 claims abstract 2
- 238000001514 detection method Methods 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 28
- 238000011033 desalting Methods 0.000 claims description 21
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 18
- 238000004108 freeze drying Methods 0.000 claims description 16
- 238000002390 rotary evaporation Methods 0.000 claims description 12
- 238000001542 size-exclusion chromatography Methods 0.000 claims description 10
- 230000005526 G1 to G0 transition Effects 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 238000005349 anion exchange Methods 0.000 claims description 8
- 238000010828 elution Methods 0.000 claims description 8
- WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000741 silica gel Substances 0.000 claims description 6
- 229910002027 silica gel Inorganic materials 0.000 claims description 6
- 150000002500 ions Chemical class 0.000 claims description 5
- 238000010606 normalization Methods 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 239000007832 Na2SO4 Substances 0.000 claims description 3
- 229940099552 hyaluronan Drugs 0.000 claims description 2
- 150000002482 oligosaccharides Chemical class 0.000 abstract description 56
- 238000000926 separation method Methods 0.000 abstract description 42
- 239000000945 filler Substances 0.000 abstract description 7
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 4
- 239000002245 particle Substances 0.000 abstract description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 12
- 238000004587 chromatography analysis Methods 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000003456 ion exchange resin Substances 0.000 description 6
- 229920003303 ion-exchange polymer Polymers 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000009066 Hyaluronoglucosaminidase Human genes 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 3
- 229920001287 Chondroitin sulfate Polymers 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- 229940059329 chondroitin sulfate Drugs 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 238000002305 strong-anion-exchange chromatography Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 238000010612 desalination reaction Methods 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical class O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 229910001410 inorganic ion Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000005461 lubrication Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Inorganic materials [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010060932 Postoperative adhesion Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002772 monosaccharides Chemical group 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/02—Acyclic radicals
- C07H7/033—Uronic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811346941.5A CN109517012B (zh) | 2018-11-13 | 2018-11-13 | 一种透明质酸寡糖的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811346941.5A CN109517012B (zh) | 2018-11-13 | 2018-11-13 | 一种透明质酸寡糖的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109517012A CN109517012A (zh) | 2019-03-26 |
CN109517012B true CN109517012B (zh) | 2020-05-22 |
Family
ID=65776471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811346941.5A Active CN109517012B (zh) | 2018-11-13 | 2018-11-13 | 一种透明质酸寡糖的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109517012B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110028598A (zh) * | 2019-04-29 | 2019-07-19 | 扬州中福生物技术有限公司 | 一种优化透明质酸分子量分布的方法 |
CN110982862B (zh) * | 2019-12-27 | 2022-05-06 | 华熙生物科技股份有限公司 | 一种大规模制备高纯度不饱和透明质酸二糖的方法 |
FR3105922B1 (fr) | 2020-01-08 | 2022-12-02 | Le Rouge Francais | Composition cosmétique pour le traitement des lèvres sous forme de solide compact contenant au moins un agent probiotique et au moins un composé choisi parmi l'acide hyaluronique et ses dérivés. |
CN113683779B (zh) * | 2021-09-09 | 2023-02-24 | 苏州快乐猩球生物科技有限公司 | 一种透明质酸光诱导载体、制备方法及应用 |
CN113736105A (zh) * | 2021-09-09 | 2021-12-03 | 苏州快乐猩球生物科技有限公司 | 一种透明质酸纳米凝胶粒子、制备方法及应用 |
CN114316085B (zh) * | 2021-12-22 | 2023-06-02 | 北京佗林医药科技有限公司 | 一种顺式透明质酸六糖及其制备方法和用途 |
CN114609296B (zh) * | 2022-03-29 | 2024-01-05 | 水羊化妆品制造有限公司 | 一种酶解透明质酸寡糖混合物的检测方法 |
CN114574532B (zh) * | 2022-03-29 | 2024-05-14 | 水羊化妆品制造有限公司 | 一种透明质酸二四六糖的制备方法 |
CN115774066B (zh) * | 2022-11-16 | 2024-08-27 | 南京乐韬生物科技有限公司 | 一种分析超低分子量透明质酸组分比例的方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0346467A1 (en) * | 1987-12-26 | 1989-12-20 | Kyowa Hakko Kogyo Co., Ltd. | Process for purifying hyaluronic acid |
CN100369925C (zh) * | 2000-07-07 | 2008-02-20 | 生化学工业株式会社 | 透明质酸低聚糖级分及含有该物质的药品 |
CN105949348A (zh) * | 2016-05-03 | 2016-09-21 | 广东东阳光药业有限公司 | 一种透明质酸分子量分级方法 |
CN106399428A (zh) * | 2016-09-29 | 2017-02-15 | 江南大学 | 一种高效分离制备单一分子量透明质酸寡糖的方法 |
CN106518934A (zh) * | 2016-11-21 | 2017-03-22 | 苏州大学 | 不饱和透明质酸奇数寡糖及其制备方法 |
-
2018
- 2018-11-13 CN CN201811346941.5A patent/CN109517012B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0346467A1 (en) * | 1987-12-26 | 1989-12-20 | Kyowa Hakko Kogyo Co., Ltd. | Process for purifying hyaluronic acid |
CN100369925C (zh) * | 2000-07-07 | 2008-02-20 | 生化学工业株式会社 | 透明质酸低聚糖级分及含有该物质的药品 |
CN105949348A (zh) * | 2016-05-03 | 2016-09-21 | 广东东阳光药业有限公司 | 一种透明质酸分子量分级方法 |
CN106399428A (zh) * | 2016-09-29 | 2017-02-15 | 江南大学 | 一种高效分离制备单一分子量透明质酸寡糖的方法 |
CN106518934A (zh) * | 2016-11-21 | 2017-03-22 | 苏州大学 | 不饱和透明质酸奇数寡糖及其制备方法 |
Non-Patent Citations (2)
Title |
---|
High-performance capillary electrophoresis separation of hyaluronan oligosaccharides produced byStreptomyces hyalurolyticus hyaluronate lyase;Francesca Maccari,等;《Carbohydrate Polymers》;20041231;第56卷;第55-63页 * |
Large-scale preparation,purification,and characterization of hyaluronan oligosaccharides from 4-mers to 52-mers;Akira Tawada,等;《Glycobiology》;20021231;第12卷(第7期);第421-426页 * |
Also Published As
Publication number | Publication date |
---|---|
CN109517012A (zh) | 2019-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109517012B (zh) | 一种透明质酸寡糖的制备方法 | |
Sanz et al. | Recent developments in sample preparation for chromatographic analysis of carbohydrates | |
US20210155720A1 (en) | Method for Preparing Hyaluronan Odd-numbered Oligosaccharides by Double Enzyme Hydrolysis | |
CN114288308B (zh) | 一种以四糖为主的透明质酸寡糖组合物及其制备方法和应用 | |
CN112694541B (zh) | 一种黄蜀葵花多糖的温和脱色方法 | |
US20240254530A1 (en) | Non-animal chondroitin sulfate oligosaccharide and preparation method thereof | |
CN114591448A (zh) | 一种桑树桑黄子实体甘露半乳聚糖及其制备和用途 | |
CN114574532A (zh) | 一种透明质酸二四六糖的制备方法 | |
CN107043431B (zh) | 细菌性荚膜多糖的纯化方法 | |
Safarik et al. | Magnetic cation exchange isolation of lysozyme from native hen egg white | |
CN102019213B (zh) | 一种壳聚糖强酸性离子交换介质的制备方法 | |
CN115944549A (zh) | 透明质酸寡糖组合物及其制备方法和用途 | |
CN106399428B (zh) | 一种高效分离制备单一分子量透明质酸寡糖的方法 | |
CN112961891A (zh) | 利用双相酶促反应制备淫羊藿苷的方法 | |
CN104774827A (zh) | 一种以鲍鱼内脏为原料制备褐藻胶裂解酶的方法 | |
CN110038524B (zh) | 一种用于分离纯化壳聚糖酶的亲和层析介质的制备方法 | |
Schmid et al. | Preparation of cellodextrins and isolation of oligomeric side components and their characterization | |
CN112107590B (zh) | 鱼鳔来源肝素类粘多糖在制备血管生成抑制剂中的应用 | |
JPH04309501A (ja) | アラビノキシロオリゴ糖 | |
Delattre et al. | Purification of oligouronides using hollow-fiber membrane functionalised with L-histidine | |
CN103864942B (zh) | 中分子量羟乙基淀粉及其提纯方法 | |
JP2010053259A (ja) | ヒアルロン酸及び/又はその塩の精製法 | |
Qin et al. | Detection and separation of chito/chitin oligosaccharides | |
CN108872409A (zh) | 一种特定分子量透明质酸分离纯化的方法 | |
CN106046066B (zh) | 一种纯化制备高纯度木二糖的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 250000 Tianchen Street 678, Jinan Hi-tech Development Zone, Shandong Province Applicant after: BLOOMAGE BIOTECH Co.,Ltd. Applicant after: SHANDONG BLOOMAGE HYINC BIOPHARM Corp.,Ltd. Address before: 250101 678 Tianchen street, hi tech Development Zone, Ji'nan, Shandong Applicant before: BLOOMAGE FREDA BIOPHARM Co.,Ltd. Applicant before: SHANDONG BLOOMAGE HYINC BIOPHARM Corp.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211129 Address after: Tianchen Avenue, Ji'nan hi tech Development Zone of Shandong Province, No. 678 250101 Patentee after: BLOOMAGE BIOTECH Co.,Ltd. Patentee after: SHANDONG BLOOMAGE HYINC BIOPHARM Corp.,Ltd. Patentee after: Huaxi Biotechnology (Tianjin) Co.,Ltd. Address before: 250000 Tianchen Street 678, Jinan Hi-tech Development Zone, Shandong Province Patentee before: BLOOMAGE BIOTECH Co.,Ltd. Patentee before: SHANDONG BLOOMAGE HYINC BIOPHARM Corp.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230621 Address after: Tianchen Avenue, Ji'nan hi tech Development Zone of Shandong Province, No. 678 250101 Patentee after: BLOOMAGE BIOTECH Co.,Ltd. Patentee after: Huaxi Biotechnology (Tianjin) Co.,Ltd. Address before: Tianchen Avenue, Ji'nan hi tech Development Zone of Shandong Province, No. 678 250101 Patentee before: BLOOMAGE BIOTECH Co.,Ltd. Patentee before: SHANDONG BLOOMAGE HYINC BIOPHARM Corp.,Ltd. Patentee before: Huaxi Biotechnology (Tianjin) Co.,Ltd. |